IP Library Assignment 059439/0940
Patent Assignment
Reel/Frame 059439/0940

Assignment of Assignor's Interest

Recorded: 2022-03-18 Pages: 6
Assignor
BORODIC, GARY E.
Executed: 2016-03-23
Assignee
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
1261 FURNACE BROOK PARKWAY, QUINCY, MASSACHUSETTS, 02169
Covered Property (1)
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Application: 15/905,616 →
Publication: US 2019/0262438
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 18, 2022
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059436/0131 →
Security Interest Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Release of Security Interest Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
Security Interest Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Security Interest Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Security Interest Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →